These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25422223)

  • 41. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.
    Yuan H; Niu YM; Wang RX; Li HZ; Chen N
    Genet Mol Res; 2011 Nov; 10(4):3356-64. PubMed ID: 22179996
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies.
    Wu KG; He XF; Li YH; Xie WB; Huang X
    Tumour Biol; 2014 Nov; 35(11):11243-59. PubMed ID: 25113251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of genetic polymorphisms in DNA repair genes
    Alsagaby S; Ahmed AA; Rasheed Z; Althwab SA; Aljohani ASM; Alhumaydhi FA; Alhomaidan HT; Alkhamiss AS; Alkhowailed M; Alaqeel A; Alblihed MA; Alrehaili J; Fernández N; Abdulmonem WA
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(5-6):530-554. PubMed ID: 35319340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymorphisms of DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln), and the risk of age-related cataract: a meta-analysis.
    Liu XC; Liu XF; Hu ZD; Li ZH
    Curr Eye Res; 2015 Jul; 40(7):676-82. PubMed ID: 25285569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significant association of XPD Asp312Asn polymorphism with breast cancer in Taiwanese patients.
    Wang HC; Liu CS; Wang CH; Tsai RY; Tsai CW; Wang RF; Chang CH; Chen YS; Chiu CF; Bau DT; Huang CY
    Chin J Physiol; 2010 Apr; 53(2):130-5. PubMed ID: 21793320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis.
    Feng Z; Ni Y; Dong W; Shen H; Du J
    Mol Biol Rep; 2012 Jan; 39(1):57-69. PubMed ID: 21614524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association between ERCC2 Asp312Asn polymorphism and breast cancer risk: a meta-analysis involving 22,766 subjects.
    Yao L; Qiu LX; Yu L; Yang Z; Yu XJ; Zhong Y; Hu XC; Yu L
    Breast Cancer Res Treat; 2010 Aug; 123(1):227-31. PubMed ID: 20127278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis.
    Zhu S; Zhang H; Tang Y; Wang J
    Urol Int; 2012; 89(2):233-40. PubMed ID: 22890093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies.
    Qin Q; Zhang C; Yang X; Zhu H; Yang B; Cai J; Cheng H; Ma J; Lu J; Zhan L; Liu J; Liu Z; Xu L; Sun X
    PLoS One; 2013; 8(11):e79864. PubMed ID: 24260311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The ERCC2/XPD Lys751Gln polymorphism affects DNA repair of benzo[a]pyrene induced damage, tested in an in vitro model.
    Xiao S; Cui S; Lu X; Guan Y; Li D; Liu Q; Cai Y; Jin C; Yang J; Wu S; van der Straaten T
    Toxicol In Vitro; 2016 Aug; 34():300-308. PubMed ID: 27139774
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single nucleotide polymorphisms (SNPs) of ERCC2, hOGG1, and XRCC1 DNA repair genes and the risk of triple-negative breast cancer in Polish women.
    Smolarz B; Makowska M; Samulak D; Michalska MM; Mojs E; Wilczak M; Romanowicz H
    Tumour Biol; 2014 Apr; 35(4):3495-502. PubMed ID: 24402573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of xeroderma pigmentosum group D (Asp312Asn, Lys751Gln) and cytidine deaminase (Lys27Gln, Ala70Thr) polymorphisms with outcome in Chinese non-small cell lung cancer patients treated with cisplatin-gemcitabine.
    Zhou M; Ding YJ; Feng Y; Zhang QR; Xiang Y; Wan HY
    Genet Mol Res; 2014 Apr; 13(2):3310-8. PubMed ID: 24841663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis.
    Duan XL; Gong H; Zeng XT; Ni XB; Yan Y; Chen W; Liu GL
    Asian Pac J Cancer Prev; 2012; 13(7):3299-303. PubMed ID: 22994751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. XPD polymorphisms, cigarette smoking, and bladder cancer risk: a meta-analysis.
    Wang M; Gu D; Zhang Z; Zhou J; Zhang Z
    J Toxicol Environ Health A; 2009; 72(11-12):698-705. PubMed ID: 19492231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Common polymorphisms in the XPD and hOGG1 genes are not associated with the risk of colorectal cancer in a Polish population.
    Sliwinski T; Krupa R; Wisniewska-Jarosinska M; Pawlowska E; Lech J; Chojnacki J; Blasiak J
    Tohoku J Exp Med; 2009 Jul; 218(3):185-91. PubMed ID: 19561388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LEP and LEPR polymorphisms in non-Hodgkin lymphoma risk: a systematic review and pooled analysis.
    Lin HY; Shi H; Li CY; Chen QC; Huang TB; Liu PC; Lou LM
    J BUON; 2015; 20(1):261-8. PubMed ID: 25778326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk.
    Long XD; Ma Y; Zhou YF; Yao JG; Ban FZ; Huang YZ; Huang BC
    BMC Cancer; 2009 Nov; 9():400. PubMed ID: 19919686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between XPD Lys751Gln polymorphism and bladder cancer susceptibility: an updated and cumulative meta-analysis based on 6,836 cases and 8,251 controls.
    Li S; Zeng XT; Ruan XL; Liu TZ; Wang XH
    Mol Biol Rep; 2014 Jun; 41(6):3621-9. PubMed ID: 24510389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of XPD Lys751Gln gene polymorphism with susceptibility and clinical outcome of colorectal cancer in Pakistani population: a case-control pharmacogenetic study.
    Gul S; Khan A; Raza A; Khan I; Ehtisham S
    Genes Genomics; 2020 Dec; 42(12):1389-1398. PubMed ID: 33025549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.
    Hansen RD; Sørensen M; Tjønneland A; Overvad K; Wallin H; Raaschou-Nielsen O; Vogel U
    Mutat Res; 2007 Jun; 619(1-2):68-80. PubMed ID: 17363013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.